Medilis appoints Makin as VP
Oncology contract research organization Medelis has appointed Inder Makin, MD, PhD, as vice president, devices & radiological health.
The Phoenix-based company said that under Makin’s leadership it expects to expand its services to medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies.
Over the last 20 years Makin has been active in strategy development and implementation of medical device technology from lab to market. He is a co-founder of Guided Therapy Systems, Ulthera and Xthetix. He has been involved in the basic and applied research of ultrasound-tissue interaction, sound-bubble interaction and propagation of high-intensity ultrasound through tissue-like media. He has published more than 20 scientific papers, chaired various national and international conferences and holds eight patents.
The Phoenix-based company said that under Makin’s leadership it expects to expand its services to medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies.
Over the last 20 years Makin has been active in strategy development and implementation of medical device technology from lab to market. He is a co-founder of Guided Therapy Systems, Ulthera and Xthetix. He has been involved in the basic and applied research of ultrasound-tissue interaction, sound-bubble interaction and propagation of high-intensity ultrasound through tissue-like media. He has published more than 20 scientific papers, chaired various national and international conferences and holds eight patents.